8RN-14603-46356
4 vaccinations
5 coded responses
48 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 191 / PA
- Registered
- 2021-02-15
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Registered dependents
GJQ-51259-71901
Child or adolescent in my care · Male · 2022-06-23
Timeline
-
2021-02-15
Registered in v-safe
-
2021-02-15
Dose 1 — Moderna
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-03-01
- 2021-03-08
-
2021-03-15
Dose 2 — Moderna
- 2021-03-15
-
2021-03-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Chills, Fatigue or tirednessAdult check-in
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-29
- 2021-04-05
-
2021-04-12
Survey response — day 28, dose 2MedDRA: Pyrexia — Feeling: GoodFree text: Mild feverMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-19
- 2021-04-26
- 2021-06-14
- 2021-09-13
-
2021-11-30
Dose 3 — Moderna
- 2021-11-30
-
2021-12-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-12-02
- 2021-12-03
- 2021-12-04
- 2021-12-05
- 2021-12-06
- 2021-12-07
- 2021-12-14
- 2021-12-21
- 2021-12-28
-
2022-01-04
Survey response — day 35, dose 3MedDRA: Cough, Secretion discharge — Feeling: GoodFree text: Mild cough and mucus that is worse at night.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-11
- 2022-03-03
- 2022-05-31
-
2022-11-15
Dose 4 — Moderna
- 2022-11-30
-
2022-11-30
Survey response — 12 months, dose 3MedDRA: COVID-19, Hand-foot-and-mouth disease, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID, hand foot mouth disease, potential RSV or other respiratory virus, nausea and fatigue associated with pregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-12-06
- 2022-12-13
- 2022-12-22
- 2022-12-27
-
2023-02-14
Survey response — 3 months, dose 4MedDRA: Oropharyngeal pain — Feeling: FairMedDRA releases: 2024-11
-
2023-05-16
Survey response — 6 months, dose 4MedDRA: Cough, Laryngitis, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-15 | Moderna | |
| 2 | 2021-03-15 | Moderna | |
| 3 | 2021-11-30 | Moderna | No |
| 4 | 2022-11-15 | Moderna | No |
Free text
Release 7 — day 28, dose 2
Symptoms: Mild fever
Release 10 — day 35, dose 3
Symptoms: Mild cough and mucus that is worse at night.
Release 12 — 12 months, dose 3
Symptoms: COVID, hand foot mouth disease, potential RSV or other respiratory virus, nausea and fatigue associated with pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Laryngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Secretion discharge | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release